Comparing Thulio and Holmium Laser Techniques for Prostate Surgery in Men with BPH

What this Trial Is About

Researchers are evaluating laser enucleation techniques for treating benign prostatic hyperplasia BPH, focusing on comparing a new pulsed thulium laser Thulio with the established holmium laser enucleation of the prostate HoLEP. These methods are considered size-independent and recommended by the American Urological Association due to favorable outcomes and fewer complications compared to older procedures. The study aims to assess differences in surgical outcomes and safety between these laser technologies. Participants will be randomly assigned to receive either the holmium laser or the pulsed thulium laser for prostate enucleation. The procedure involves removing prostate tissue using these laser devices during surgery. The study includes one follow-up evaluation after the procedure to monitor recovery and effectiveness. Both groups will be compared on various surgical and postoperative parameters. Throughout the study, participants will be assessed before surgery and once after surgery for outcomes such as hemostasis time during surgery, blood loss, operative and laser parameters, symptom scores, quality of life, urine flow tests, and catheterization duration. Researchers will monitor safety and recovery up to 30 days post-operation. The total involvement includes the surgical procedure and one follow-up visit to evaluate results and any complications.

Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate